Tumour suppression by p53: a role for the DNA damage response?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nature Reviews. Cancer

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc2716PMID 19730431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.

  2009cited by this paper
• Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.

  2009cited by this paper
• Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

  2009cited by this paper
• A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.

  2009cited by this paper
• Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2

  2009cited by this paper
• beta-tting on p63 as a metastatic suppressor.

  2009cited by this paper
• Eating to exit: autophagy-enabled senescence revealed.

  2009cited by this paper
• Autophagy mediates the mitotic senescence transition.

  2009cited by this paper
• The Absence of Ser389 Phosphorylation in p53 Affects the Basal Gene Expression Level of Many p53-Dependent Genes and Alters the Biphasic Response to UV Exposure in Mouse Embryonic Fibroblasts

  2008cited by this paper
• Living on a break: cellular senescence as a DNA-damage response

  2008cited by this paper
• p53: A new player in reproduction

  2008cited by this paper
• p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK

  2008cited by this paper
• Living on a break: cellular senescence as a DNA-damage response.

  2008cited by this paper
• Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains.

  2008cited by this paper
• Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.

  2008cited by this paper
• Transcriptional control of human p53-regulated genes

  2008cited by this paper
• Apoptosis: controlled demolition at the cellular level

  2008cited by this paper
• Mechanisms of regulatory diversity within the p53 transcriptional network

  2008cited by this paper
• An Oncogene-Induced DNA Damage Model for Cancer Development

  2008cited by this paper
• A complex barcode underlies the heterogeneous response of p53 to stress

  2008cited by this paper
• Restoration of p53 function leads to tumour regression in vivo

  2007cited by this paper
• Tumor Suppressor Dosage Regulates Stem Cell Dynamics during Aging

  2007cited by this paper
• Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome

  2007cited by this paper
• Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

  2007cited by this paper
• Crippling p53 activities via knock-in mutations in mouse models

  2007cited by this paper
• p53 in health and disease

  2007cited by this paper
• The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.

  2007cited by this paper
• The ARF/Oncogene Pathway Activates p53 Acetylation within the DNA Binding Domain

  2007cited by this paper
• MDM2 and MDM4: p53 regulators as targets in anticancer therapy.

  2007cited by this paper
• Cellular senescence: when bad things happen to good cells

  2007cited by this paper
• p53 regulates maternal reproduction through LIF

  2007cited by this paper
• p63 and p73 in human cancer: defining the network

  2007cited by this paper
• Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression

  2006cited by this paper
• p14ARF Activates a Tip60-Dependent and p53-Independent ATM/ATR/CHK Pathway in Response to Genotoxic Stress

  2006cited by this paper
• Molecular recognition of p53 and MDM2 by USP7/HAUSP

  2006cited by this paper
• Control of cell migration: a tumour suppressor function for p53?

  2006cited by this paper
• Critical role for Daxx in regulating Mdm2

  2006cited by this paper
• Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation*

  2006cited by this paper
• p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling

  2006cited by this paper
• Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

  2006cited by this paper
• Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

  2006cited by this paper
• Dual-site regulation of MDM2 E3-ubiquitin ligase activity.

  2006cited by this paper
• p53 ubiquitination: Mdm2 and beyond.

  2006cited by this paper
• p53 Regulates Mitochondrial Respiration

  2006cited by this paper
• TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

  2006cited by this paper
• Regulation of AIF expression by p53

  2006cited by this paper
• Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

  2006cited by this paper
• Untargeted effects of ionizing radiation: implications for radiation pathology.

  2006cited by this paper
• A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.

  2006cited by this paper
• The central region of HDM2 provides a second binding site for p53

  2006cited by this paper
• Tumour biology: Policing of oncogene activity by p53

  2006cited by this paper
• Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

  2006cited by this paper
• Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4

  2006cited by this paper
• p63 protects the female germ line during meiotic arrest

  2006cited by this paper
• The pathological response to DNA damage does not contribute to p53-mediated tumour suppression

  2006cited by this paper
• A global map of p53 transcription-factor binding sites in the human genome.

  2006cited by this paper
• Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

  2006cited by this paper
• Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo.

  2006cited by this paper
• Cancer: Crime and punishment

  2005cited by this paper
• Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.

  2005cited by this paper
• Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.

  2005cited by this paper
• Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

  2005cited by this paper
• DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

  2005cited by this paper
• Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

  2005cited by this paper
• AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

  2005cited by this paper
• Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas.

  2005cited by this paper
• ATM and Chk2‐dependent phosphorylation of MDMX contribute to p53 activation after DNA damage

  2005cited by this paper
• The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

  2005cited by this paper
• Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.

  2005cited by this paper
• Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.

  2005cited by this paper
• ATM-Mediated Phosphorylations Inhibit Mdmx/Mdm2 Stabilization by HAUSP in Favor of p53 Activation

  2005cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• MDM2 and prognosis.

  2004cited by this paper
• Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice

  2004cited by this paper
• p63 and p73 are not required for the development and p53-dependent apoptosis of T cells.

  2004cited by this paper
• Handbook of cell signaling

  2004cited by this paper
• ATM activity contributes to the tumor-suppressing functions of p14ARF

  2004cited by this paper
• p63 and p73: roles in development and tumor formation.

  2004cited by this paper
• Increased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389

  2004cited by this paper
• Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity

  2004cited by this paper
• Intrinsic tumour suppression

  2004cited by this paper
• Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation

  2004cited by this paper
• A dynamic role of HAUSP in the p53-Mdm2 pathway.

  2004cited by this paper
• Defective apoptosis and B‐cell lymphomas in mice with p53 point mutation at Ser 23

  2004cited by this paper
• Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation*

  2004cited by this paper
• Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors

  2004cited by this paper
• ATM and related protein kinases: safeguarding genome integrity

  2003cited by this paper
• A splicing mutation affecting expression of ataxia–telangiectasia and Rad3–related protein (ATR) results in Seckel syndrome

  2003cited by this paper
• Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts

  2003cited by this paper
• Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis

  2003cited by this paper
• Tumor suppression by Ink4a-Arf: progress and puzzles.

  2003cited by this paper
• Differential regulation of E2F1 apoptotic target genes in response to DNA damage

  2003cited by this paper
• Phosphorylation Site Interdependence of Human p53 Post-translational Modifications in Response to Stress*

  2003cited by this paper
• Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

  2003cited by this paper
• Involvement of the INK4a/Arf gene locus in senescence

  2003cited by this paper
• p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In Vivo

  2002cited by this paper
• DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.

  2002cited by this paper
• Chk2 Is a Tumor Suppressor That Regulates Apoptosis in both an Ataxia Telangiectasia Mutated (ATM)-Dependent and an ATM-Independent Manner

  2002cited by this paper
• 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer

  2002cited by this paper
• Mutation of Mouse p53 Ser23 and the Response to DNA Damage

  2002cited by this paper

• Proteomic analysis of cisplatin-induced spermatogenesis defects in mice

  2026cites this paper
• Hepatitis C Virus Core Induces p53 Ser-15 Phosphorylation to Facilitate E6-Associated Protein-Mediated Proteasomal Degradation of p53

  2026cites this paper
• Identification of MKRN1 as a key modulator of the p53-MDM2 feedback loop.

  2026cites this paper
• E6‐associated protein induces ubiquitin‐dependent proteasomal degradation of p53 phosphorylated at Ser‐15 in response to genotoxic stress

  2026cites this paper
• Orientia tsutsugamushi modulates p53, the cell cycle, and genotoxicity to maintain its intracellular niche

  2025cites this paper
• Heavy Metal Toxicity in Clarias gariepinus Exposed to Water Samples Around Cement Factory, Ogun State

  2025cites this paper
• A Chemotherapy Response-Related Gene Signature and DNAJC8 as Key Mediators of Hepatocellular Carcinoma Progression and Drug Resistance

  2025cites this paper
• Determination of p53 biomarker with a smart electrochemical biosensor based on brush polymer-functionalized disposable electrode

  2025cites this paper
• p53 regulates glucose metabolic reprogramming in MASLD-related hepatocellular carcinoma via modulating mitochondrial pyruvate carriers.

  2025cites this paper
• Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma: Structural, transcriptomic and in vitro insights

  2025cites this paper
• Distinct Stem Cell Identities Converge into Shared Erythroid Stress in ERCC6L2 Disease and Shwachman-Diamond Syndrome

  2025cites this paper
• Аутофагия: клеточная гибель или способ выживания?

  2025cites this paper
• p53-regulated SESN1 and SESN2 regulate cell proliferation and cell death through control of STAT3

  2025cites this paper
• CD47 blockade enhances cisplatin sensitivity by inhibiting DNA repair gene expression.

  2025cites this paper
• Assessing the Biological Impacts and Health Risks of UV Radiation in the Context of Sustainable Development Goals: Review

  2025cites this paper
• Beyond the Hayflick Limit: How Microbes Influence Cellular Aging.

  2025cites this paper
• Insights into the nucleolar dysfunction and associated genetic disorders

  2025cites this paper
• Baicalein Inhibits Proliferation, Migration, and Invasion of Mesothelioma Cells Through the p53–FOXM1 Signaling Axis

  2025cites this paper
• The totipotent 2C‐like state safeguards genomic stability of mouse embryonic stem cells

  2024cites this paper
• Loss of Brcc3 in Zebrafish Embryos Increases Their Susceptibility to DNA Damage Stress

  2024cites this paper
• Multiscale simulations reveal the driving forces of p53C phase separation accelerated by oncogenic mutations

  2024cites this paper
• The function of histone methyltransferase SETDB1 and its roles in liver cancer

  2024cites this paper
• Nuclear functions regulated by the VRK1 kinase

  2024cites this paper
• PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signaling

  2024cites this paper
• Induced Pluripotent Stem Cell-Derived Fibroblasts Efficiently Engage Senescence Pathways but Show Increased Sensitivity to Stress Inducers

  2024cites this paper
• Extracellular vesicle-associated DNA: ten years since its discovery in human blood

  2024cites this paper
• Unraveling the Guardian: p53’s Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

  2024cites this paper
• A NRAS mRNA G-quadruplex structure-targeting small-molecule ligand reactivating DNA damage response in human cancer cells for combination therapy with clinical PI3K inhibitors.

  2024cites this paper
• SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.

  2024cites this paper
• Transcriptional and functional regulation of cell cycle and UV response by PPARβ in human skin epidermal cells

  2024cites this paper
• Cellular senescence: mechanisms and relevance to cancer and aging

  2024cites this paper
• B-Myb deficiency boosts bortezomib-induced immunogenic cell death in colorectal cancer

  2024cites this paper
• Exploring the Role of p53 in Radiosensitivity: A Key Player in Cancer Therapy

  2024cites this paper
• DNA Damage Triggers the Activation of Immune Response to Viral Pathogens via Salicylic Acid in Plants

  2023cites this paper
• Residual Foci of DNA Damage Response Proteins in Relation to Cellular Senescence and Autophagy in X-Ray Irradiated Fibroblasts

  2023cites this paper
• The role of truncated p53 isoforms in the DNA damage response.

  2023cites this paper
• Targeting p53 pathways: mechanisms, structures and advances in therapy

  2023cites this paper
• The mechanism accounting for DNA damage strength modulation of p53 dynamical properties

  2023cites this paper
• The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets

  2023cites this paper
• Regulation of Oocyte Apoptosis: A View from Gene Knockout Mice

  2023cites this paper
• Dehydrocostus Lactone Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Modulating p53-p21-CDK2 Signaling Pathway

  2023cites this paper
• Olfactomedin-4 deletion exacerbates DSS-induced colitis through a matrix metalloproteinase-9-dependent mechanism

  2023cites this paper
• Hydroxytyrosol's effect on the expression of apoptosis and oxidative stress related genes in BE (2)-C neuroblastoma cell line

  2023cites this paper
• Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing tumour protein 53 gene status

  2023cites this paper
• Differential effects of pesticides on dioxin receptor signaling and p53 activation

  2023cites this paper
• A dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response

  2023cites this paper
• CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor

  2023cites this paper
• Deer antlers: the fastest growing tissue with least cancer occurrence

  2023cites this paper
• Sirtuin 1 inhibition: a promising avenue to suppress cancer progression through small inhibitors design

  2023cites this paper
• The combined characteristics of cholesterol metabolism and the immune microenvironment may serve as valuable biomarkers for both the prognosis and treatment of hepatocellular carcinoma

  2023cites this paper
• C9orf72 poly‐PR helps p53 escape from the ubiquitin‐proteasome system and promotes its stability

  2023cites this paper
• DNA induced CTAB-caped gold bipyramidal nanoparticles self-assembly using for Raman detection of DNA molecules.

  2023cites this paper
• MDM2 Implications for Potential Molecular Pathogenic Therapies of Soft-Tissue Tumors

  2023cites this paper
• Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process

  2023cites this paper
• Role of sestrins in metabolic and aging-related diseases

  2023cites this paper
• TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma

  2023cites this paper
• Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage

  2022cites this paper
• Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma

  2022cites this paper
• Signaling pathways and therapeutic interventions in gastric cancer

  2022cites this paper
• Cell cycle progression defects and impaired DNA damage signaling drive enlarged cells into senescence

  2022cites this paper
• ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma

  2022influential citation
• Single-cell analysis of p53 transitional dynamics unravels stimulus- and cell type-dependent signaling output motifs

  2022cites this paper
• Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression

  2022cites this paper
• In vitro assays for investigating the FLASH effect

  2022cites this paper
• RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2

  2022cites this paper
• Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity

  2022cites this paper
• Development of a fluorescence reporter system to quantify transcriptional activity of endogenous p53 in living cells

  2022cites this paper
• Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines

  2022cites this paper
• p53 as a unique target of action of cisplatin in acute leukaemia cells

  2022cites this paper
• RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC

  2022cites this paper
• Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1

  2021cites this paper
• Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.

  2021cites this paper
• β-TrCP1 facilitates cell cycle checkpoint activation, DNA repair, and cell survival through ablation of β-TrCP2 in response to genotoxic stress

  2021cites this paper
• Methylglyoxal induces p53 activation and inhibits mTORC1 in human umbilical vein endothelial cells

  2021cites this paper
• Quinofuracins F – I, new quinofuracin derivatives produced by Staphylotrichum boninense PF1444

  2021cites this paper
• Single-cell transitional dynamics unravel stimulus- and cell type-dependent signaling outputs of distinct p53 regulatory feedback motifs

  2021cites this paper
• Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas

  2021cites this paper
• Transcriptomic analysis of DNA damage response in zebrafish embryos under simulated microgravity

  2021cites this paper
• Delineating the Switch between Senescence and Apoptosis in Cervical Cancer Cells under Ciclopirox Treatment

  2021cites this paper
• Chemo-Preventive Action of Resveratrol: Suppression of p53—A Molecular Targeting Approach

  2021cites this paper
• Photoreaction of DNA Containing 5‐Halouracil and its Products †

  2021cites this paper
• Hops/Tmub1 Heterozygous Mouse Shows Haploinsufficiency Effect in Influencing p53-Mediated Apoptosis

  2021cites this paper
• p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies

  2021cites this paper
• Ethnicity-stratified analysis of the association between P53 rs1042522 polymorphism and women HPV infection: A meta-analysis.

  2021cites this paper
• Dynamic stem cell selection safeguards the genomic integrity of the epidermis.

  2021cites this paper
• Cancer Genetics and Epigenetics in Cancer Risk Assesment

  2021cites this paper
• Polydatin gold nanoparticles potentiate antitumor effect of doxorubicin in Ehrlich ascites carcinoma‐bearing mice

  2021cites this paper
• SETDB1 in cancer: overexpression and its therapeutic implications.

  2021cites this paper
• Replication stress promotes cell elimination by extrusion

  2021cites this paper
• Dynamic behavior of the p53-Mdm2 core module under the action of drug Nutlin and dual delays.

  2021cites this paper
• Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation

  2021cites this paper
• Revisiting ageless antiques; synthesis, biological evaluation, docking simulation and mechanistic insights of 1,4-Dihydropyridines as anticancer agents.

  2021cites this paper
• Cyclin‐Dependent Protein Kinases in the Control of Cell Cycle in Plants

  2020cites this paper
• New physiological insights into the phenomena of deer antler: A unique model for skeletal tissue regeneration

  2020cites this paper
• Fluorescent image-based high-content screening of extracts of natural resources for cell cycle inhibitors and identification of a new sesquiterpene quinone from the sponge, Dactylospongia metachromia.

  2020cites this paper
• ATM and P53 differentially regulate pancreatic beta cell survival in Ins1E cells

  2020cites this paper
• Diverse functions of deadenylases in DNA damage response and genomic integrity

  2020cites this paper
• Awakening the HSC: Dynamic Modeling of HSC Maintenance Unravels Regulation of the TP53 Pathway and Quiescence

  2020cites this paper
• Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate-4-thiazolinone hybrid derivatives.

  2020cites this paper
• Regulating tumor suppressor genes: post-translational modifications

  2020cites this paper